SEC Form 4 · accession 0001140361-16-058349
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 7:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Mar 15, 2016 | M | 5,975 | $33.70 | A | 150,852 | D | |
| ResMed Common Stock | Mar 15, 2016 | S | 5,975 | $58.57 | D | 144,877 | D | |
| ResMed Common StockF4 | Mar 16, 2016 | A | 8,097 | $0.00 | A | 152,974 | D | |
| ResMed Common Stock | Mar 16, 2016 | F | 4,226 | $0.00 | D | 148,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | Mar 15, 2016 | M | 5,975 | D | Nov 11, 2010 | Nov 11, 2017 | ResMed Commmon Stock | 5,975 | 45,125 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable. Options vest 1/4 annually.
- F3Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted March 1, 2013, with a three-year performance period. The shares were earned and vested March 16, 2016, when the ResMed compensation committee certified performance.
- F4Shares earned, based on performance, at 40% of the target award.
- F5Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted March 1, 2013.